1
0
0
(1 - 17 von 20
)
ACS Publications
pubs.acs.org
von S Yamano · · Zitiert von: 207 — ... Michel Eichelbaum, Matthias Schwab, Ulrich M. Zanger. Genetic variability of CYP2B6 in populations of African and Asian origin: allele ...
Eichelbaum, Michel [WorldCat Identities]
worldcat.org
Most widely held works by Michel Eichelbaum. Stereochemical aspects of drug action and disposition( Book ) 10 editions published between and in ...
Category:Michel Eichelbaum - Wikimedia Commonscommons.wikimedia.org › wiki › Category:Michel_...
commons.wikimedia.org
· Media in category "Michel Eichelbaum". This category contains only the following file. Michel Eichelbaum Portrait.jpg 840 × 1,301; 134 KB.
A role for constitutive androstane receptor in the regulation of...
www.degruyter.com
Oliver Burk 1 / Katja A. Arnold 2 / Anke Geick 3 / Heike Tegude 4 / Michel Eichelbaum 5
identification of a normal and two variant cDNAs derived from ...American Chemical Society
pubs.acs.org
von S Yamano · · Zitiert von: 202 — ... Kathrin Klein, Michel Eichelbaum, Matthias Schwab, Ulrich M Zanger Eduardo Barbosa-Sicard, Wolf-Hagen Schunck, Michel Eichelbaum, ... › doi › abs
Wikimedia Commons
commons.wikimedia.org
English: Photograph of German pharmacologist Michel Eichelbaum. Date, 25 October Source, Michel Eichelbaum. Author, Michel Eichelbaum. Permission (Reusing ...
File:Eichelbaum1.jpg - Wikimedia Commons
commons.wikimedia.org
— Date, 20 December Source, DRawing by Michel Eichelbaum. Author, Michel Eichelbaum. Permission (Reusing this file) ... › F...
Leopoldina
www.leopoldina.org
Michel Eichelbaum ist ein deutscher Internist und Experte für klinische Pharmakologie. Er widmete sich vor allem dem Antiepileptikum Carbamazepin und dem ...
CYP2D6 Polymorphisms as Predictors of Outcome in ...AACR Journals
aacrjournals.org
von W Schroth · · Zitiert von: 110 — Michel Eichelbaum;. Michel Eichelbaum. Authors' Affiliations: 1Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and University ... › article-a...
Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on ...Oxford University Press
academic.oup.com
von HJ Ribaudo · · Zitiert von: 152 — Michel Eichelbaum,. Michel Eichelbaum Dr Margarete Fischer-Bosch Institute for Clinical Pharmacology, University of Tuebingen. › jid
ABCB1 Genotype of the Donor but Not of the Recipient Is a Major ...jasn.asnjournals.org › content › abstract
jasn.asnjournals.org
... Wegner, Jan Gossmann, Hanns Ackermann, Christian Seidl, Berthold Hocher, Ulrich M. Zanger, Helmut Geiger, Michel Eichelbaum and Matthias Schwab.
CYP2D6 Polymorphisms as Predictors of Outcome in Breast Cancer ...aacrjournals.org › clincancerres › article-abstract
aacrjournals.org
Michel Eichelbaum;. Michel Eichelbaum. Authors' Affiliations: 1Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and University ...
GastroJournal.org
www.gastrojournal.org
von M Schwab · · Zitiert von: 84 — Michel Eichelbaum. Michel Eichelbaum. Affiliations. Dr.Margarete Fischer-Bosch Institute of Clinical Pharmacology, Department of Internal Medicine, Oncology ...
Oxford Academic
academic.oup.com
von H Brauch · · Zitiert von: 203 — Michel Eichelbaum ,. Michel Eichelbaum. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology. , Stuttgart, Germany. University Tübingen. , Tübingen ...
When good drugs go bad - NASA/ADS
ui.adsabs.harvard.edu
How can we best reduce the risk of severe adverse reactions to marketed drugs? An international group of scientists argues that a global research network is...
aacrjournals.org
aacrjournals.org
von M Rokavec · · Zitiert von: 20 — ... Michel Eichelbaum;. Michel Eichelbaum. 1Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology and. 3University of Tübingen and. Search ...
ashpublications.org
ashpublications.org
von M Stanulla · · Zitiert von: 53 — Michel Eichelbaum,. Michel Eichelbaum. 2Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;. Search for other works by this ...
sortiert nach Relevanz / Datum